Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Incidence and survival of hypopharyngeal cancer: a Danish Nation-Wide Study from 1980 to 2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. IL-6 release from muscles during exercise is stimulated by lactate-dependent protease activity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Electrochemotherapy for Breast Cancer-Results From the INSPECT Database

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Electrochemotherapy is now in routine clinical use to treat cutaneous metastases of any histology, and is listed in national and international guidelines for cutaneous metastases and primary skin cancer. Electrochemotherapy is used by dermatologists, surgeons, and oncologists, and for different degrees and manifestations of metastases to skin and primary skin tumours not amenable to surgery. This treatment utilises electric pulses to permeabilize cell membranes in tumours, thus allowing a dramatic increase of the cytotoxicity of anti-cancer agents. Response rates, often after only one treatment, are very high across all tumour types. The most frequent indications are cutaneous metastases from malignant melanoma and breast cancer. In 2006, standard operating procedures (SOPs) were written for this novel technology, greatly facilitating introduction and dissemination of the therapy. Since then considerable experience has been obtained treating a wider range of tumour histologies and increasing size of tumours which was not originally thought possible. A pan-European expert panel drawn from a range of disciplines from dermatology, general surgery, head and neck surgery, plastic surgery, and oncology met to form a consensus opinion to update the SOPs based on the experience obtained. This paper contains these updated recommendations for indications for electrochemotherapy, pre-treatment information and evaluation, treatment choices, as well as follow-up.

OriginalsprogEngelsk
TidsskriftActa oncologica (Stockholm, Sweden)
Vol/bind57
Udgave nummer7
Sider (fra-til)874-882
Antal sider9
ISSN0284-186X
DOI
StatusUdgivet - jul. 2018

ID: 56581811